Added to YB: 2024-03-27
Pitch date: 2024-01-20
MEDP [bullish]
Medpace Holdings, Inc.
+89.1%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.9B
Pitch Price
$298.83
Price Target
N/A
Dividend
N/A
EV/EBITDA
19.52
P/E
28.39
EV/Sales
4.63
Sector
Life Sciences Tools and Services
Category
N/A
Show full summary:
ClearBridge Investments SMID Cap Growth Strategy New Position: Medpace Holdings, Inc.
MEDP: New position. Provides clinical research-based drug & medical device development services for emergent biotech customers. Specific customer focus allows continued market share capture & growth within the industry. One-stop shop is a competitive advantage.
Read full article (1 min)